ASNC-ACC-Letter-to-Congress_Price-Transparency-Legislation_02-01-2024
In February 2024, ASNC and the American College of Cardiology shared with Senate leaders concerns about the implications of Section 4 of S.3458, the Health Care PRICE Transparency Act 2.0, which posed an unnecessary administrative burden on already strained physician practices and would not have resulted in a patient-centric solution to price transparency. Section 4 would likely have impacted the vast majority of physicians, ranging from small family practices to specialists—all of whom provide imaging services in the office setting.
Resource Type
Health Policy Memos
Related Resources
PET Case: The Mystery of Chest Pain with Patent Grafts
Case summary: This case illustrates the added value of myocardial blood flow…
PET Case: PET/CT for Complex Coronary Disease
Case summary: This case illustrates the role of multimodality imaging in a…
Cardiovascular Organizations Comment on OMB Proposed Regulation on Federal Financial Assistance
ASNC-ACC-ASE-SCAI-SCCT_Comments letter to OMB_07-13-2026